AstraZeneca’s COVID-19 vaccine could be approved in the UK ‘shortly after Christmas’ – says top scientist Oxford
Investors are getting too optimistic, Jefferies global strategists say – they see it as a repeat of 2019
European stocks and US futures are soaring despite Trump’s threat to derail the COVID-19 support bill
